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In vertebrates, seven signal transducer and activator of transcription
(STAT) proteins bind to palindromic sites separated by spacers of two
or three nucleotides (STAT1), four nucleotides (STAT6) or three
nucleotides (STAT2 to STAT5a/b). This diversity of binding sites
provides specificity to counter semiredundancy and was thought to
be a recent evolutionary acquisition. Here, we examine the natural
DNA-binding sites of the single Drosophila Stat and show that this is
not the case. Rather, Drosophila Stat92E is able to bind to and
activate target gene expression through both 3n and 4n spaced sites.
Our experiments indicate that Stat92E has a higher binding affinity for
3n sites than for 4n sites and suggest that the levels of target gene
expression can be modulated by insertion and/or deletion of single
bases. Our results indicate that the ancestral STAT protein had the
capacity to bind to 3n and 4n sites and that specific STAT binding
preferences evolved with the radiation of the vertebrate STAT family.
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INTRODUCTION
The Janus kinase (JAK)/signal transducer and activator of transcrip-
tion (STAT) signalling pathway was originally discovered in
vertebrates on the basis of its transduction of activation of
g-interferon (Darnell, 1997; Levy & Darnell, 2002). Analysis of the
pathway rapidly identified a family of seven closely related STATs as
well as many pathway-activating cytokines, several receptors and
four JAK kinases. The seven STAT transcription factors share several
features including an SH2 domain, an invariant tyrosine residue
phosphorylated as a result of the activation of STAT, and a
characteristic DNA-binding domain. According to the established
canonical model, activation of the JAK/STAT pathway by cytokine
signalling brings about tyrosine phosphorylation of cytoplasmic
STATs and leads to their dimerization. This complex translocates to
the nucleus where it binds to DNA, thus activating target gene
transcription (Kisseleva et al, 2002; Levy & Darnell, 2002). STAT
DNA-binding sites, also known as Gamma interferon activation site
(GAS) elements, consist of an essential core comprising the
palindromic sequence TTC(n)GAA where n represents a spacer of
2–4 nucleotides. STAT6 shows a preference for 4n spacing, whereas
other STATs preferentially bind to 3n, although they can also bind to
2n sites with low affinity (Ehret et al, 2001).
The Jak/Stat pathways identified in invertebrates seem to be
much simpler. Of these, only Drosophila has a ‘complete’
pathway comprising three unpaired-like cytokines (Upd, Upd2
and Upd3); one receptor (Domeless; Dome); one JAK kinase (Hop)
and one Stat (Stat92E; Binari & Perrimon, 1994; Hou et al, 1996;
Yan et al, 1996; Harrison et al, 1998; Brown et al, 2001; Chen
et al, 2002; Agaisse et al, 2003; Hombrı ´a et al, 2005; reviewed in
Hombrı ´a & Brown, 2002; Arbouzova et al, 2006).
In vitro site selection and electrophoretic mobility shift assays
(EMSAs) showed that Drosophila Stat has a binding preference for
sites with 3n spacing (Yan et al, 1996). In vivo, Stat92E binding of
3n sites was confirmed for the even skipped (eve) gene (Small
et al, 1996). In cell culture, it was also shown that Drosophila raf
(Draf) and Suppressor of cytokine signalling at 36E (Socs36E),
enhancers containing 3n sites are activated by Jak/Stat (Kwon et al,
2000; Baeg et al, 2005; Mu ¨ller et al, 2005). Furthermore,
vertebrate 3n GAS elements act as reporters for the activation of
Stat in Drosophila melanogaster and in Caenorhabditis elegans
(Gilbert et al, 2005; Wang & Levy, 2006).
These data suggest that the ancestral STAT bound to 3n sites
and that the preference for sites with other spacing evolved after
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1114the vertebrate STAT radiation. Here, we present evidence that the
converse is true, with binding site plasticity of STAT transcription
factors representing an ancestral state. We show that Drosophila
Stat is able to activate transcription through 4n sites. We show that
Stat binds to 3n sites with higher affinity in vitro, and that the
transformation of 4n into 3n sites increases the activation of Stat
targets both in vitro and in vivo. These observations clarify how
the Stat binding preferences evolved and illustrate an unantici-
pated plasticity of DNA binding that will help in the definition of
direct Stat targets outside the vertebrate lineage.
RESULTS AND DISCUSSION
Stat92E activates dome through 4n sites
Upd expressed in the ectoderm of the Drosophila pharynx and
hindgut signals to the adjacent mesoderm where it enhances
dome transcription (Hombrı ´a et al, 2005). This effect is mediated
by a mesoderm-specific enhancer (dome-MESO) present in the
first intron of the dome gene (Hombrı ´a et al, 2005). To prove that
this enhancer is regulated directly by Stat, we searched for
potential Stat92E-binding sites [TTC(3n)GAA] in dome-MESO
(Fig 1A; Yan et al, 1996) and identified three such sites at the
30 end of the reporter. However, a 1.2-kb lacZ construct, dome-SB,
containing these 3n sites, is unable to drive mesodermal
expression (Fig 1C), whereas the complementary 1.6-kb proximal
fragment, dome-SL, reproduces the dome-MESO pattern of
expression (Fig 1D). The subdivision of this fragment locates
the enhancer within a 746-bp fragment that we named dome-SLF2
(Fig 1A,E). Although no canonical 3n sites are present in SLF2, five
4n sites are present—a sequence bound in vertebrates by the
STAT6 protein (Ehret et al, 2001). As previous in vitro binding site
selection experiments using Stat92E isolated the 3n sites exclu-
sively, we set out to test whether Drosophila Stat92E could bind to
4n sites in vivo.
To identify which of the five potential sites drive mesodermal
regulation, we compared the first intron sequence of dome in
several Drosophilidae (Drosophila 12 Genomes Consortium,
2007). The only conserved sequence is a 43bp element contain-
ing the third and fourth D. melanogaster Stat 4n sites (Fig 1B). To
test the possible function of these two sites, we made an SLF2
construct with the conserved third and fourth 4n sites mutated
(SLF2*MUT), a 137-bp fragment containing only the two 4n sites
present within the 43bp conserved region (SLF4), and an SLF4
construct with these two 4n sites mutated (SLF4*MUT; Fig 1B).
Analysis of SLF2*MUT shows that mutation of the third and
fourth 4n sites results in the almost complete loss of mesoderm
expression (Fig 1F), although low levels of expression were still
observed at late embryogenesis.
The SLF4 fragment alone is able to drive expression in the
mesoderm of the pharynx and hindgut. The expression of SLF4 is
more variable than that of SLF2 with some insertions showing
expression exclusively in the pharynx (Fig 1G), whereas others
showing low levels of general mesoderm expression in addition to
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Fig 1 |Stat regulates dome transcription through 4n sites. (A) Schematic representation of the dome gene showing the localization of the putative
Stat-binding sites. Sites in the first intron are represented by black (3n) or red (4n) asterisks. (B) Comparison of the conserved SLF4 region in several
Drosophilidae. The element has two putative Stat sites with varying spacer lengths as indicated by the tree branch colours (4n4n (red), 4n3n (orange)
and 2n3n (green)). Asterisks under the sequence label the putative Stat-binding sites and red dashes indicate the mutated bases in the SLF2*MUT and
SLF4*MUT.( C) The SB first intron fragment containing the 3n sites does not drive expression in the embryo. The SL (D) and the SLF2 (E) fragments
drive expression in the pharynx and hindgut. (F) Simultaneous mutation of the conserved third and fourth Stat-binding sites in SLF2*MUT abolishes
most expression from the pharynx and hindgut, although low levels remain at late stages. (G) The SLF4 fragment drives expression, albeit at low
levels, in the pharynx and hindgut. Hindgut expression is only observed in inserts with higher levels of expression (compare G with Fig 2C).
(H) Mutation of both Stat-binding sites abolishes pharynx and hindgut expression in SLF4*MUT. This particular line has been chosen as it has
Jak/Stat-independent expression in the amnioserosa (white arrow) that acts as an internal control for staining. Mutation of only one conserved Stat
site in SLF2, either the third site (I) or the fourth site (J), is not sufficient to abolish the expression (compare wild-type SLF2 in (E) with (I) and
(J) with the double mutant in (F)). The tree in (B) is modified from the assembly, alignment and annotation of 12 species as published in FlyBase.
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1115expression in the pharynx and hindgut (Fig 2C). Mutation of the 4n
sites in SLF4*MUT is sufficient to ablate all expression in both the
pharynx and the hindgut (Fig 1H).
The lower levels of expression of SLF4 relative to those of SLF2
in the pharynx and hindgut and the slight remnant expression
observed in the pharynx of SLF2*MUT embryos suggest that some
of the non-conserved 4n sites might contribute to dome-MESO
expression. We tested whether both of the conserved 4n sites in
SLF2 are necessary by independently mutating them (Fig 1I,J).
Mutation of a single site is not sufficient to abolish mesoderm
expression, indicating that these sites are redundant in the context
of the SLF2 enhancer.
To confirm that SLF2 and SLF4 are responsive to Jak/Stat
signalling, we studied their expression in Df(1)os1A mutants that
lack all Upd ligands. As expected, SLF2 expression disappeared
from the pharynx and hindgut (Fig 2A,B) and the same is true for
SLF4 (Fig 2C,D). Conversely, ectopic activation of the pathway by
expression of Upd or Upd2 using the ectoderm-specific 69B-Gal4
line activates SLF2 (Fig 2E; data not shown) and SLF4 (Fig 2F) in the
mesoderm. This ectopic activation requires the conserved 4n sites
as it is not observed in SLF2*MUT (Fig 2G) or SLF4*MUT (Fig 2H).
The dome-MESO enhancer and its derivatives are expressed
specifically in the mesoderm, suggesting that Stat is interacting
with tissue-specific cofactors. We tested whether dome-MESO
could also be activated in the ectoderm if Upd was co-expressed
with various mesoderm-specific proteins. We observed ectopic
ectoderm expression after co-expression of Upd with Tinman (Tin;
Fig 2I,I0), but not with Dmef2, Bagpipe or Biniou (Fig 2J,J0; data not
shown). This suggests that Tin or one of its downstream targets is a
STAT cofactor necessary for dome activation in the mesoderm.
The requirement for this interaction explains why only the 4n sites
in dome-MESO are functional.
Stat92E binds to 4n and 3n sites with different affinity
To test whether Stat92E can bind to the conserved 4n sites in vitro,
oligonucleotides containing these sites (known as 4n Dome3 and
4n Dome4; Fig 3A) were used in EMSAs together with a Stat92E–
GFP (green fluorescent protein) fusion protein activated by co-
expression of the constitutively active Jak allele HopTuml (Luo et al,
1995; Karsten et al, 2006). By using the established 3n wild-type
consensus (Yan et al, 1996) as a positive control, a strong band is
detectable (Fig 3B, arrow) that is supershifted by the addition of
the GFP antibody (Fig 3B, arrowhead). The same binding
conditions with the 4n Dome3 and 4n Dome4 sites also give
clear band shifts that can be supershifted (and possibly stabilized)
by anti-GFP (Fig 3B). However, 4n band shifts are considerably
weaker than those produced by the 3n control under these in vitro
conditions. We next tested whether 4n Dome sites could compete
with wild-type radiolabelled 3n sites (3n wild type) for binding to
activated Stat92E–GFP. Although unlabelled 3n wild-type-binding
sites are strong competitors (Fig 3C, lanes 1–3), a 50-fold excess of
mutant 3n-binding sites is not able to compete with labelled 3n
wild type (Fig 3C, lane 14). By contrast, unlabelled 4n Dome3
and, to a lesser extent, 4n Dome4 sites can compete with the
labelled 3n wild-type probe (Fig 3C, lanes 6 and 9). A Dome3þ4
probe containing both 4n sites separated by their D. melanogaster
spacer (Fig 1B) at 25-fold excess (Fig 3C, lane 12—a concentration
that provides a 50-fold excess of 4n sites) produces stronger
competition than the equivalent concentration of either 4n site
alone, suggesting that two adjacent sites are able to bind Stat92E
better than a single binding site in isolation.
To measure in vivo the relative transcriptional activation
potential of activated Stat92E–GFP at these sites, we devised a
luciferase reporter plasmid containing either four 3n-o r4 n-binding
sites (Fig 3D; Methods). By using these reporters in an established
Kc167 cell-based model (Mu ¨ller et al, 2005), we stimulated cells by
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Fig 2 |Expression of SLF2 and SLF4 depends on Jak/Stat pathway activity.
(A)A nSLF2 line in wild type. This insertion has expression on the
amnioserosa unrelated to the enhancer. (B) The same insertion as in
(A)i naDf(1)os1A embryo lacking all upd genes. The expression in the
pharynx and hindgut disappears, whereas the unrelated amnioserosa
staining persists, acting as an internal control for staining levels.
(C) A wild-type SLF4 strong insertion. (D) The same insertion in a
Df(1)os1A background. (E,F) Ectopic upd in the ectoderm driven by the
69B-Gal4 line induces ectopic SLF2 (E) or SLF4 (F) expression in the
mesoderm. (G,H) Ectopic upd does not induce ectopic expression when
the two conserved Stat-binding sites are mutated as in SLF2*MUT
(G)o ri nSLF4*MUT (H). (I) Simultaneous expression in the ectoderm of
upd and tin can activate dome-MESO in the ectoderm. (J) Simultaneous
expression of upd and Dmef2 does not result in the activation of
dome-MESO in the ectoderm. (I0,J0) Close-up views of the ventral side of
the embryos in (I,J) showing the position of the ectoderm and mesoderm
cells. Only Upd and Tin co-expression can activate the enhancer in the
ectoderm. In both cases, because of the presence of the endogenous
mesodermal cofactors, there is mesodermal enhancer expression.
dome-MESO, domeless-mesoderm-specific enhancer; Jak, Janus kinase;
Stat, signal transducer and activator of transcription.
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1116either co-expressing the Upd ligand or the activated Jak HopTuml
(Luo et al, 1995). Under these conditions, both 3n and 4n reporters
show significantly increased levels of activity over the unstimu-
lated state, with the 3n reporter around twice as active as the 4n
reporter (Fig 3E). Finally, we found that the SB 3n sites (Figs 1A,3A)
can bind to Stat92E in vitro (Fig 3F), underscoring the importance
of cofactors for the activity of Stat in vivo.
Comparison of the conserved SLF4 region in various
Drosophilidae (Fig 1B) shows that species closely related to
D. melanogaster share the 4n spacing of the Stat fourth site, with
3n sites present in more distantly related drosophilids. In some
species in which the fourth site is 3n, the third site has a 2n spacer.
The above experiments suggest that changes in spacer length
during evolution might modulate the levels of transcription of
target genes. To test this possibility, we mutated the fourth 4n
spacer in SLF4 to a 3n spacer as observed in the obscura group.
The resulting enhancer drove higher levels of expression in
D. melanogaster than did SLF4 (Fig 4A,B), indicated by the
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Fig 3 |Drosophila Stat binds to 3n and 4n sites with various affinities. (A) Sequences of the oligonucleotides used in (B,C,F). SB1, SB2 and SB3
correspond to the potential Stat-binding sites present in the SB fragment (Fig 1A), and Dome3, Dome4 and Dome3þ4 correspond to the
D. melanogaster Stat-binding sites in SLF4 (Fig 1A,B). 3n wild type (WT) corresponds to the Stat92E-binding site consensus (Yan et al, 1996).
(B) EMSA assay using the radiolabelled binding sites indicated and showing binding activities that are detectable after co-transfection of plasmids
expressing Stat92E–GFP and the constitutively active HopTuml proteins. Specific shifted bands corresponding to DNA:Stat92E–GFP (arrow) and
DNA:Stat92E–GFP complexes supershifted with anti-GFP (arrowhead) are indicated. (C) EMSA assay using radiolabelled 3n WT to detect activated
Stat92E–GFP-binding activity. Each lane contains the same quantity of cell extract and labelled 3n WT-binding site and was co-incubated with the
indicated fold excess of unlabelled competitor sites. (D) Schematic representation of the reporters used in (E) with black boxes representing Stat-
binding sites. Underlined bases represent the core Stat92E-binding sequence. Another thymine residue (bold) was inserted into each binding site
of 2x2Draf 3n to create the 4n reporter. (E) Firefly luciferase activity in cells transfected with the reporters shown in (D) and co-transfected with
plasmids expressing either the pathway ligand unpaired or the constitutively active Jak HopTuml. Levels were normalized to a co-transfected
constitutively expressed Renilla luciferase plasmid and are expressed as fold change over unstimulated state. (F) EMSA assay of unactivated and
activated Stat92E–GFP binding to radiolabelled WT, SB1, SB2 and SB3 oligonucleotides. EMSA, electrophoretic mobility shift assay; GFP, green
fluorescent protein; MUT, mutated; STAT, signal transducer and activator of transcription.
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1117consistent appearance of hindgut expression in all insertions.
Further mutation in this enhancer of the third-site to a 2n spacer,
as in D. virilis, restored the levels of expression similar to the
original SLF4 enhancer (Fig 4C). These results indicate that varying
the relative number of 3n compared with 4n sites might control
the level of expression of Stat targets during evolution.
The direct Stat target crb is regulated through 4n sites
To determine whether other Drosophila Stat target genes are
controlled through 4n sites, we analysed the Stat-dependent crb
spiracle-specific enhancer (Fig 5A,B; Lovegrove et al, 2006).
Simultaneous mutation of the three putative Stat-binding sites (one
3n and two 4n sites) reduces crb spiracle expression (Fig 5C).
Mutation of the 3n site has little effect on the expression of
enhancer (Fig 5D), whereas mutation of both 4n sites (Fig 5E)
results in levels of expression similar to those obtained after
mutation of both the 3n and 4n sites.
Our results highlight the limitations of bioinformatic and
in vitro DNA-binding analyses as sole methods for defining
transcription-factor-binding sites if they overlook low-affinity
binding sites that might be functional in vivo because of
tissue-specific cofactors.
The capacity of Drosophila Stat to activate through both 3n and
4n sites suggests that the ancestral Stat protein had the ability to
bind to both sites. This capacity has been retained in Drosophila
and possibly in other invertebrates. Intriguingly, this suggests that
the Drosophila Stat protein dimer has some flexibility in its ability
to bind to DNA sites with different spacing. The loss of this
flexibility after the radiation of the vertebrate STATs might have
resulted in the differential 3n compared with 4n binding
preferences observed in mammalian STAT proteins. In vertebrates,
the specialization of various STAT proteins for different binding
sites might have been advantageous for acquiring target specificity
(Seidel et al, 1995), although it is possible that vertebrate STATs
can also activate targets through low binding affinity sites. In
Drosophila, in which it has been shown that Upd acts as
morphogen (Xi et al, 2003), maintaining Stat binding flexibility
might be advantageous, as the evolution of the number of
Stat-binding sites and their spacer length could provide a flexible
system to modulate the distance from the source at which a given
Stat target could be activated.
METHODS
Constructs and directed mutagenesis. All reporter constructs
were generated in phs43lacZ. To create the SB and SL reporters,
the dome-MESO 2.8-kb enhancer fragment (Hombrı ´a et al, 2005)
was subdivided into a distal (SB) EcoRV-BamH1 and a proximal
NotI-EcoRV (SL) fragment. PCR amplification of the SL fragment
with the primers TAGGAGGGGAACTGGGATGG and ATGTTT
GGCCTCGAAATTGC generated 746bp SLF2. Amplification with
CGAATACGTTAGGGCGAGCC and GTACATCGGCACTTCGG
ACG created 138bp SLF4. Amplified fragments were subcloned
into pGEMT and from there into phs43lacZ.
The conserved Stat sites in SLF4 and SLF2 were in vitro
mutagenized into TTCCGCTGTT, the third site, and AACGTCC
GAA, the fourth site (Fig 1B), using QuikChange (Stratagene;
www.stratagene.com) and appropriate PAGE-purified primers to
create SLF2*MUT and SLF4*MUT. These sites were mutated
independently in SLF2 to create SLF2MUT3rd and SLF2MUT4th.
The same sites were also mutated to create various spacer variants
of SLF4. In SLF4 4n3n, the fourth site was mutated to
TTC.TCCGAA where (.) indicates a deleted G. In SLF4 2n3n,
apart from this deletion, the third site was mutated to TTCC..TGAA
where (..) indicates deleted GC.
The wild-type crb43.2 enhancer and the triple mutant
Stat-binding-site spiracle enhancer have been described earlier
(Lovegrove et al, 2006). The mutations in the triple mutant (---)
were TTCCATGCC (for 3n), TTCGTTTGTT (for 50 4n) and
TTCAGGGGTT (for 30 4n). In the 3n mutated construct (-4n4n),
the 3n site was TTCCATGTT. In the double 4n mutant construct
SLF4 2n3n
SLF4 4n3n
SLF4 4n4n
Fig 4 |Various Stat spacer lengths modify in vivo transcriptional
activation. (A) Levels of expression of the SLF4 enhancer containing
the normal 4n4n D. melanogaster Stat-binding sites. (B) Enhanced
expression of an SLF4 enhancer in which the conserved fourth Stat 4n
site is transformed to 3n.( C)A nSLF4 enhancer in which the third site
has been transformed to 2n and there is a 3n site transformation on the
fourth site. Note that the levels of expression in (C) are lower than those
in (B), and more similar to those of (A). Stat, signal transducer and
activator of transcription.
crb
2 kb
spiracle crb43.2-lacZ
3n 4n4n
3n4n4n
* **
Fig 5 |The crb gene is regulated by Stat through 4n sites. (A) Schematic
representation of the crb gene showing the localization in the spiracle
enhancer of the putative Stat-binding sites analysed (red asterisks (4n
sites), black asterisk (3n site)). (B) Expression of the spiracle enhancer
in the wild type. (C) Expression in the triple 3n4n4n mutant (---).
(D) Expression in the 3n mutant site (-4n4n). (E) Expression in the
double 4n4n mutant sites (3n--). Stat, signal transducer and activator
of transcription.
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1118(3n--), the sites were transformed to TTCGTTTGTT (50 4n) and
TTCAGGGGTT (30 4n). For each construct, several independent
inserts were analysed using anti-b-galactosidase. For SLF4,
SLF2*MUT and SLF4*MUT, 10 inserts were studied in each case
to confirm that the expression was consistent. All fly strains have
been described by Hombrı ´a et al (2005). Df(1)os1A is a deletion
for all three Upd ligands (Upd, Upd2 and Upd3).
Electrophoretic mobility shift assays. EMSAs to detect DNA
binding of Stat92E were undertaken as described by Karsten
et al (2006). Double-stranded DNA probes were generated
by annealing GGAGGGTTCCGCTGAAAAT and GACATTTTCA
GCGGAACCC (4n Dome3), GGACAATTCGTCCGAAGTG and
GACCACTTCGGACGAATTG (4n Dome4), GGAGGGTTCCGCT
GAAAATGTTTATTTTTAACAATTCGTCCGAAGTG and GACC
ACTTCGGACGAATTGTTAAAAATAAACATTTTCAGCGGAACCC
(4n Dome3þ4), GGAATTTTCATAGAATCA and GACTGATTC
TATGAAAAT (3n SB1), GGAGGTTTCATGGAAATC and GAC
GATTTCCATGAAACC (3n SB2), GGACGATTCCGAGAACTG and
GACCAGTTCTCGGAATCG (3n SB3), GGATTTTTCCCGGAA
ATG and GACCATTTCCGGGAAAAA (3n wild type) or GGATTT
TTGCCGCAAATG and GACCATTTGCGGCAAAAA (3n MUT).
The recessed ends of annealed oligonucleotide pairs were filled in
using Klenow polymerase and dNTPs containing either 32P-g-
dCTP (to generate radioactive probes) or unlabelled dNTPs (to
generate cold competitors). EMSAs shown in Fig 3B,F used
0.15pmol of radiolabelled probe per lane and 50mgml  1 poly
dI-dC, whereas supershifts included 0.3ml a-GFP antibody
(Abcam; www.abcam.com). For competition assays (Fig 3C),
binding to 0.06pmol of radiolabelled 3n wild-type probe was
assayed in the presence of either 0, 0.6 or 3pmol of unlabelled
Dome3, Dome4, 3pmol 3n MUT or 0.3, 1.5 or 3pmol of
Dome3þ4 added as competitor with 83mgml  1 poly dI-dC.
Luciferase assays. The 2x2Draf 3n luciferase reporter is based on
the p50-663Drafwt-luc originally containing two 3n Stat-binding
sites (Kwon et al, 2000) that we duplicated to generate a reporter
containing four 3n sites. We also generated another version of
p50-663Drafwt-luc in vitro which was mutated to include another
spacer nucleotide that we duplicated to generate a reporter
containing four 4n sites (known as 2x2Draf 4n).
Transformation of the 3n to 4n sites was generated in vitro
using the QuikChange method (Stratagene) and the oligonucleo-
tides GGGGATCCTAAAATTCGTCGGAAAGTAATAAAATTCGT
CGGAAAGTAAAGATCCCCCG and CGGGGGATCTTTACTTTC
CGACGAATTTTATTACTTTCCGACGAATTTTAGGATCCCC (un-
derlined bases represent the core Stat92E-binding sequence and
bold indicates the added base). Both the original 3n and the newly
generated 4n vectors were then multimerized by cutting out the
binding sites using BamHI and XbaI, filling in and re-ligating into
the parental vector cut SmaI to generate 2x2Draf 3n and 2x2Draf
4n, respectively. Constructs were sequence verified. Activity
assays were undertaken in Kc167 cells as described by Mu ¨ller
et al (2005). Equal quantities of both 3n and 4n reporters were
transfected for each experiment repeated in quadruplicate and
normalized to unstimulated background activity.
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